Sunitinib in clinical practice: The expanded access program for metastatic renal cell carcinoma - Abstract
Friday, 19 March 2010
Praxis für interdisziplinäre Onkologie und Hämatologie, Freiburg i.Br.
read more
|
Monitoring of metastatic renal cell carcinoma - standards and challenges - Abstract
Friday, 19 March 2010
Klinik für Onkologie und Hämatologie, Krankenhaus Nordwest, Frankfurt/M.
read more
|
Complex percutaneous resections for upper-tract urothelial carcinoma - Abstract
Friday, 19 March 2010
Steven B. Streem Center for Endourology, Glickman Urological and Kidney Institute , Cleveland Clinic Foundation, Cleveland, Ohio.
read more
|
Renal medullary-like carcinoma in an adult without sickle cell hemoglobinopathy - Abstract
Friday, 19 March 2010
Section of Hematology/Oncology and Department of Medicine, The University of Chicago, 5841 South Maryland Avenue, MC 2115, Chicago, IL 60637, USA.
read more
|
First-line therapy of metastatic renal cell carcinoma - update 2009 - Abstract
Thursday, 18 March 2010
Klinik für Urologie, Charité Berlin.
read more
|
Current aspects of second-line and sequence therapy of metastatic renal cell carcinoma - Abstract
Thursday, 18 March 2010
Urologische Klinik und Poliklinik der Technischen Universität, München, Klinikum rechts der Isar, München.
read more
|
Beyond the Abstract - Absolute preoperative C-reactive protein predicts metastasis and mortality in the first year following potentially curative nephrectomy for clear cell renal cell carcinoma, by Viraj Master, MD and Tim Johnson, MD
Wednesday, 17 March 2010
BERKELEY, CA (UroToday.com) - Approximately 30% of patients with localized renal cell carcinoma (RCC) will proceed to develop metastases following potentially curative nephrectomy.
Login to read more...
|
Skeletal-related events in urological cancer patients with bone metastasis: A multicenter study in Japan. - Abstract
Wednesday, 17 March 2010
Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
read more
|
Impact of radiofrequency ablation on PBMC subpopulation in patients with renal cell carcinoma - Abstract
Wednesday, 17 March 2010
Department of Urology, Medical University of Gdan'sk, Gdan'sk, Poland.
read more
|
Sunitinib - from paradigm shift to standard treatment of metastatic renal cell carcinoma - Abstract
Wednesday, 17 March 2010
Medizinische Klinik II, Hämatologie/Onkologie, J.W. Goethe-Universität, Frankfurt/M.
read more
|
Predictive factors for ipsilateral recurrence after nephron-sparing surgery in renal cell carcinoma - Abstract
Tuesday, 16 March 2010
Department of Urology, University Hospital, Bordeaux, France.
read more
|
Should hilar lymph nodes be expected in radical nephrectomy specimens? - Abstract
Tuesday, 16 March 2010
Department of Pathology, University of Arkansas for Medical Sciences, 4301 West Markham slot # 517, Little Rock, AR 72205, USA.
read more
|
Editorial - An ex-vivo evaluation of the application and strength of a novel laparoscopic knot substitute device
Monday, 15 March 2010
BERKELEY, CA (UroToday.com) - Several suture-securing devices have been developed for laparoscopic suturing to minimize the need for intracorporeal knot tying.
Login to read more...
|
Identification of Ror2 as a hypoxia inducible factor (HIF) target in von Hippel-Lindau (VHL)-associated renal cell carcinoma - Abstract
Monday, 15 March 2010
University of North Carolina at Chapel Hill, United States.
read more
|
Prognostic factors in patients with metastatic renal cell carcinoma - Abstract
Monday, 15 March 2010
The Department of Urlogy, Sapporo Medical University School of Medicine.
read more
|
Recent advances and future directions in the management of metastatic renal cell carcinoma - Abstract
Friday, 12 March 2010
Beatson West of Scotland Cancer Centre, Glasgow, UK.
read more
|
GU Cancers Symposium 2010: ASCO ASTRO SUO - Localized kidney tumors: Pathology and diagnosis - Session Highlights
Thursday, 11 March 2010
SAN FRANCISCO, CA, USA (UroToday.com) - In this rapid-paced session, several presentations were made providing the latest updates in the pathology and diagnosis of localized kidney tumors.
Login to read more...
|
GU Cancers Symposium 2010: ASCO ASTRO SUO - Renal cancer: Surgical management of kidney tumors - Session Highlights
Thursday, 11 March 2010
SAN FRANCISCO, CA, USA (UroToday.com) - This session was comprised of two informative presentations on the surgical management of kidney tumors.
Login to read more...
|
GU Cancers Symposium 2010: ASCO ASTRO SUO - Active surveillance of an incidental renal mass in the setting of an active or recently treated non-renal malignancy - Session Highlights
Thursday, 11 March 2010
SAN FRANCISCO, CA, USA (UroToday.com) - Dr. Frances Alba, a resident from the University of Texas, presented data from MD Anderson Cancer Center evaluating the results of an active surveillance protocol of patients with an incidental renal mass with or without a separate active non renal malignancy.
Login to read more...
|
GU Cancers Symposium 2010: ASCO ASTRO SUO - Pathological upstaging does not affect survival in patients with pT2/T3 renal tumors treated by either partial nephrectomy or radical nephrectomy - Session Highlights
Thursday, 11 March 2010
SAN FRANCISCO, CA, USA (UroToday.com) - Dr. Christopher Weight presented data on patients with clinical T1 tumors treated with partial nephrectomy or radical nephrectomy who were then upstaged on pathologic examination.
Login to read more...
|
GU Cancers Symposium 2010: ASCO ASTRO SUO - Every minute counts when you clamp the renal hilum during partial nephrectomy - Session Highlights
Thursday, 11 March 2010
SAN FRANCISCO, CA, USA (UroToday.com) - Dr. Robert Thompson presented data using a joint database between the Cleveland Clinic and Mayo Clinic database on significance of warm ischemia times.
Login to read more...
|
GU Cancers Symposium 2010: ASCO ASTRO SUO - Radiofrequency ablation (RFA) of renal tumors: Clinical, radiographic, and pathologic results from a tertiary cancer center - Session Highlights
Thursday, 11 March 2010
Radiofrequency ablation (RFA) was done in 124 patients either laparoscopically or percutaneously under CT or MRI guidance for a median tumor size of 2.8 cm.
Login to read more...
|
GU Cancers Symposium 2010: ASCO ASTRO SUO - Effect of complete resection for multiple metastases of renal cell carcinoma on survival - Session Highlights
Thursday, 11 March 2010
SAN FRANCISCO, CA, USA (UroToday.com) - Dr. Angela Alt and colleagues retrospectively reviewed the records on patients with renal cell carcinoma with multiple metastases who underwent complete metastasectomy (CM) and compared them to those who did not.
Login to read more...
|
GU Cancers Symposium 2010: ASCO ASTRO SUO - Clinical activity of sunitinib rechallenge in metastatic renal cell carcinoma - Session Highlights
Thursday, 11 March 2010
SAN FRANCISCO, CA, USA (UroToday.com) - In his presentation, Dr. Brian Rini shared interesting data on the potential for re-challenge with sunitinib in patients with metastatic renal cell carcinoma who progressed during treatment with sunitinib used as first line therapy.
Login to read more...
|
GU Cancers Symposium 2010: ASCO ASTRO SUO - Does targeted therapy result in reliable and meaningful primary tumor downstaging in patients with metastatic renal cell carcinoma? - Session Highlights
Thursday, 11 March 2010
SAN FRANCISCO, CA, USA (UroToday.com) - Dr.Edwin Abel from MD Anderson Cancer Center presented a series of 143 patients with metastatic RCC treated with various targeted agents with the primary tumor in situem>.
Login to read more...
|
GU Cancers Symposium 2010: ASCO ASTRO SUO - Metastatic renal cell carcinoma - Session Highlights
Thursday, 11 March 2010
SAN FRANCISCO, CA, USA (UroToday.com) - The final session of the meeting was comprised of two excellent presentations about the treatment of metastatic renal cell carcinoma.
Login to read more...
|
An ex-vivo evaluation of the application and strength of a novel laparoscopic knot substitute device - Abstract
Thursday, 11 March 2010
Department of Urology, University of California-San Francisco, School of Medicine, San Francisco, California, USA
read more
|
Beyond the Abstract - Laparoscopic radical nephrectomy for renal cell carcinoma: Oncological outcomes at 10 years or more, by Andre Berger, MD
Tuesday, 09 March 2010
BERKELEY, CA (UroToday.com) - Key finding: Perioperative and surrogate oncologic outcomes were analyzed in the urological literature.
Login to read more...
|
Analysis shows elevated blood pressure may be associated with improved clinical outcomes in patients with kidney cancer treated with Sutent
Monday, 08 March 2010
SAN FRANCISCO, CA, USA (Press Release) - March 4, 2010
read more
|
Beyond the Abstract - The potential clinical value of FDG-PET for recurrent renal cell carcinoma, by Koya Nakatani, MD
Friday, 05 March 2010
BERKELEY, CA (UroToday.com) - The potential clinical value of FDG-PET for recurrent renal cell carcinoma
FDG-PET is applicable for staging or re-staging, and monitoring therapeutic response in several cancers.
Login to read more...
|
Plasma N-terminal pro-brain natriuretic peptide as prognostic marker in fatal cardial decompensation with sunitinib malate therapy - Abstract
Friday, 05 March 2010
Department of Urology, University of Munich, Klinikum Grosshadern, Munich, Germany.
read more
|
New strategies in kidney cancer: Therapeutic advances through understanding the molecular basis of response and resistance - Abstract
Friday, 05 March 2010
Department of Solid Tumor Oncology, Cleveland Clinic Taussig Cancer Institute, Glickman Urologic and Kidney Institute, Cleveland, Ohio.
read more
|
The use of the American Society of Anesthesiology classification as a prognostic factor in patients with renal cell carcinoma - Abstract
Thursday, 04 March 2010
Service of Urology, Department of Pelvic Surgery, Hospital AC Camargo, São Paulo, Brazil.
read more
|
Activity of a multitargeted chemo-switch regimen (sorafenib, gemcitabine, and metronomic capecitabine) in metastatic renal-cell carcinoma: A phase 2 study (SOGUG-02-06) - Abstract
Wednesday, 03 March 2010
University Hospital del Mar-IMIM, Barcelona, Spain.
read more
|
Histological subtype is an independent predictor of outcome in patients with renal cell carcinoma - Abstract
Wednesday, 03 March 2010
Department of Urology , Mayo Clinic, Rochester, Minnesota.
read more
|
Renal oncocytoma-are there sufficient grounds to consider surveillance following prenephrectomy histologic diagnosis - Abstract
Wednesday, 03 March 2010
Department of Urology, Tel-Aviv University, Assaf Harofeh Medical Center, Zerifin, Israel.
read more
|
Composite renal cell carcinoma with clear cell renal cell carcinomatous and carcinoid tumoral elements: A first case report - Abstract
Tuesday, 02 March 2010
Department of Pathology, Hopital de Brabois, CHRU Nancy, Nancy, France.
read more
|
Percutaneous biopsy of renal cell carcinoma underestimates nuclear grade - Abstract
Tuesday, 02 March 2010
Department of Urology, Roswell Park Cancer Institute, Buffalo, New York.
read more
|
Plethora of agents, plethora of targets, plethora of side effects in metastatic renal cell carcinoma - Abstract
Tuesday, 02 March 2010
Department of Medicine I, Clinical Division of Oncology and Cancer Center, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
read more
|
Statement from NIDDK Director Griffin P. Rodgers for World Kidney Day and National Kidney Month
Monday, 01 March 2010
WASHINGTON, DC, USA (Press Release) - March 1, 2010
read more
|
Nephon-sparing surgery: Our experience in open and laparoscopic approach in 254 cases - Abstract
Monday, 01 March 2010
Hospital Británico de Buenos Aires, Argentina.
read more
|
Neoadjuvant clinical trial with sorafenib for patients with stage II or higher renal cell carcinoma - Abstract
Monday, 01 March 2010
Department of Medicine, Division of Hematology and Oncology, Lineberger Comprehensive Cancer Center; Department of Surgery, Division of Urology; Department of Radiology, The University of North Carolina at Chapel Hill, Chapel Hill.
read more
|
Prognostic stratification of patients with advanced renal cell carcinoma treated with sunitinib: Comparison with the Memorial Sloan-Kettering prognostic factors model - Abstract
Monday, 01 March 2010
The treatment paradigm in advanced renal cell carcinoma (RCC) has changed in the recent years.
read more
|
Predictive value of baseline serum vascular endothelial growth factor and neutrophil gelatinase-associated lipocalin in advanced kidney cancer patients receiving sunitinib - Abstract
Friday, 26 February 2010
Medical Oncology, I.R.C.C.S. San Matteo University Hospital Foundation, Pavia, Italy.
read more
|
Changes in symptoms of renal cell carcinoma over four decades - Abstract
Friday, 26 February 2010
Department of Oncology, Tampere University Hospital, Tampere, Finland.
read more
|
Recent updates in renal cell carcinoma - Abstract
Friday, 26 February 2010
Department of Medicine, Division of Hematology and Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA.
read more
|
Shrinkage of thyroid volume in sunitinib-treated patients with renal-cell carcinoma: A potential marker of irreversible thyroid dysfunction? - Abstract
Thursday, 25 February 2010
Department of General Medical Oncology, University Hospitals Leuven , Leuven Cancer Institute, Leuven, Belgium .
read more
|
Metastatic renal cell carcinoma treated with sunitinib: Early evaluation of treatment response using dynamic contrast-enhanced ultrasonography - Abstract
Thursday, 25 February 2010
Imaging Department, Service of Biostatistics and Epidemiology, and Medical Department, Institut Gustave Roussy, Villejuif Cedex, France.
read more
|
Hyponatremia as a prognostic and predictive factor in metastatic renal cell carcinoma - Abstract
Thursday, 25 February 2010
Department of Oncology, Aarhus University Hospital, Nørrebrogade 44, 8000 Aarhus C, Denmark.
read more
|
Course offering from UC Irvine Surgical Education Center, Department of Urology: 20th anniversary of the laparoscopic nephrectomy
Thursday, 25 February 2010
Laparoscopic, Robotic and Ablative Therapies for Localized Renal Tumors Course
read more
|
Renal Cancer 
